Steven L. Fasman

Companies

• Catalent Pharma SolutionsOfficer Oct 24, 2014 to Dec 12, 2023¹
• Catalent Pharma SolutionsGeneral counsel Oct 25, 2017 to Jun 13, 2022²
• SIGA TECHNOLOGIES INCBoard member Jun 1, 2007 to Mar 11, 2011³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Catalent Pharma Solutions CTLT72,380 shares⁴Aug 24, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 24, 2023Sold 817 shares at $44.65 of Catalent Pharma Solutions⁵
• Aug 24, 2023Other 817 shares of Catalent Pharma Solutions⁴
• Aug 23, 2023Granted 2,226 shares of Catalent Pharma Solutions⁵
• Aug 23, 2023Other 2,226 shares of Catalent Pharma Solutions⁴
• Aug 1, 2023Granted 11,885 shares of Catalent Pharma Solutions⁶
• Aug 1, 2023Sold 524 shares at $47.76 of Catalent Pharma Solutions⁶
• Aug 1, 2023Sold 1,113 shares at $46.72 of Catalent Pharma Solutions⁶
• Aug 25, 2022Sold 4,811 shares at $103.04 of Catalent Pharma Solutions⁷
• Aug 24, 2022Granted 10,155 shares of Catalent Pharma Solutions⁷
• Jul 26, 2022Granted 2,788 shares of Catalent Pharma Solutions⁸
• Jul 26, 2022Sold 2,546 shares at $106.90 of Catalent Pharma Solutions⁸
• Jun 10, 2022Sold 1,951 shares at $107.54 of Catalent Pharma Solutions⁹
• Jun 10, 2022Sold 3,049 shares at $106.77 of Catalent Pharma Solutions⁹
• Jan 3, 2022Granted 4,017 shares of Catalent Pharma Solutions¹⁰
• Oct 4, 2021Sold 1,800 shares at $131.04 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Sold 4,192 shares at $130.39 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Sold 8,209 shares at $129.17 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Sold 20,513 shares at $128.56 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Exercised options 2,155 shares at $88.10 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Exercised options 6,622 shares at $54.94 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Exercised options 3,799 shares at $43.88 of Catalent Pharma Solutions¹¹
• Oct 4, 2021Exercised options 4,683 shares at $36.02 of Catalent Pharma Solutions¹¹